NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog
Lahontan Announces Closing of Upsized Private Placement of Units and Welcomes New Institutional Investor
